Experience

VectivBio to be Acquired by Ironwood

May 23, 2023

Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by Ironwood, with an estimated aggregate consideration of approximately $1 billion.

Read more

Related contacts

Michal Berkner
Partner, London
Brandon W. Fenn
Partner, New York
Rita Sobral
Associate, London
Sydney Sawyier
Associate, London
Vlad Herta
Associate, London
Sarah Curry
Associate, New York
Trevor Bossi
Associate, Boston
Lois NaYeon Yoo
Associate, New York
Ofir Hadari
Associate, New York
David Burns
Special Counsel, Washington DC
Jacqueline Grise
Partner, Washington DC
Nicollette R. Kirby
Associate, Washington DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Mary Maher Lewis
Special Counsel, Reston
Steven A. Zuckerman
Associate, New York
Stephanie Gentile
Partner, New York
Eileen Marshall
Partner, Washington DC
Rick Jantz
Associate, Los Angeles Santa Monica
Ivor Elrifi
Partner, New York
Heidi A. Erlacher
Partner, Boston
Sofia Santos
Patent Agent, Boston
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Megan Flynn
Associate, London
Joe Claffey
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche

August 6, 2022

Cooley advised Poseida Therapeutics, a clinical-stage biopharmaceutical company, on its strategic collaboration and license agreement with Roche. Lawyers Ken Krisko, Marya Postner, Bin Wang, Hajra Nashin and Brendan Haberle led the Cooley team advising Poseida. 

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Marya Postner
Partner, Palo Alto
Bin Wang
Special Counsel, Palo Alto
Hajra Nashin
Associate, San Diego
Brendan Haberle
Associate, San Diego
Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego
Sharon Connaughton
Special Counsel, Washington DC
Jacqueline Grise
Partner, Washington DC
Amanda Pacheco
Associate, Palo Alto
Jeffrey J. Tolin
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Liza Cotter
Associate, Boston
Yasmin Roland
Associate, Brussels
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Maricel Mojares-Moore
Special Counsel, San Francisco

Related Practices & Industries

Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II

December 9, 2021

Cooley advised Alvotech Holdings, a global biopharmaceutical company focused on the development and manufacturing of biosimilar medicines for patients worldwide, on its agreement to merge with special purpose acquisition company (SPAC) Oaktree Acquisition Corp. II. Lawyers Michal Berkner, Div Gupta, Nicolas Dumont and Jarrett Burks led the Cooley team advising Alvotech.

Read more

Related contacts

Michal Berkner
Partner, London
Div Gupta
Partner, New York
Nicolas H.R. Dumont
Partner, New York
Jarrett Burks
Associate, London
Vlad Herta
Associate, London
Wouter Deleersnyder
Associate, New York
Sonia Nath
Partner, Washington DC
Elizabeth Anne Wright
Partner, Brussels
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Barbara Mirza
Partner, Los Angeles Santa Monica
Stacey A. Bradford
Special Counsel, Washington DC
Rick Jantz
Associate, Los Angeles Santa Monica
Stella Sarma
Special Counsel, Brussels
Jennifer Shanley
Special Counsel, New York
Ivor Elrifi
Partner, New York
Sharon Connaughton
Special Counsel, Washington DC
David Boles
Partner, London
Alexandria Ashour
Associate, San Diego
Chris Coulter
Partner, London
David Dalton
Associate, Los Angeles Santa Monica
Neelam Atwal
Associate, London
Chris Stack
Partner, London
Alan W. Tamarelli
Partner, New York
Karen Tsai
Special Counsel, Washington DC
Wyatt Kernell
Associate, New York
Reid Hooper
Special Counsel, Washington DC
Megan Browdie
Partner, Washington DC
Sanya Sukduang
Partner, Washington DC
Alessandra Murata
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington DC
James Maton
Partner, London
Shehzad Akram
Trainee Solicitor , London
Sarah Oliai
Associate, Washington DC
Barbara Borden
Partner, San Diego
Nicola Squire
Partner, London
Peter Byrne
Partner, New York
Claire Keast-Butler
Partner, London
Charles George
Associate, London
Jill Simon
Senior Paralegal, New York
Xander Lee
Partner, Los Angeles Santa Monica
Calvin Lee
Associate, New York

Related Practices & Industries

Flexion Therapeutics Agrees to Sell to Pacira BioSciences

October 13, 2021

Cooley advised Flexion Therapeutics, a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of patients with musculoskeletal conditions, on its agreement to sell to Pacira BioSciences. Lawyers Miguel Vega, Kevin Cooper, Sean Clayton and Matthew Silverman led the Cooley team advising Flexion.

Related contacts

Miguel J. Vega
Partner, Boston
Kevin Cooper
Partner, New York
Matthew D. Silverman
Special Counsel, San Diego
Ivor Elrifi
Partner, New York
Stephanie Gentile
Partner, New York
Patrick Flanagan
Partner, New York
Jason Savich
Partner, San Francisco
Jacqueline Grise
Partner, Washington DC
Phil Mitchell
Partner, New York
Eileen Marshall
Partner, Washington DC
Peter Adams
Partner, San Diego
Mischi a Marca
Partner, San Francisco
David Navetta
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington DC
Geoffrey Spolyar
Partner, Boston
Edmond Lay
Associate, San Diego
Luke X. Blackett
Associate, San Francisco
Terren O'Connor
Associate, San Diego
Patrick Sharma
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Rubin Waranch
Associate, Washington DC
Josh Rosenholtz
Associate, Colorado
Allison Kutner
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Jennifer Shanley
Special Counsel, New York
Dani Nazemian
Special Counsel, San Diego
Alexandra Leavy
Associate, New York
Kristopher Kleiner
Special Counsel, Colorado

Related Practices & Industries

Exscientia – $510.4 Million IPO

October 6, 2021

Cooley advised Exscientia, an AI-driven pharmatech company based in Oxford, United Kingdom, on its $510.4 million initial public offering, including concurrent private placements to SoftBank and the Bill & Melinda Gates Foundation. Partners David Boles, Claire Keast-Butler, Div Gupta and Marc Recht led the Cooley team advising Exscientia.

Read more

Related contacts

David Boles
Partner, London
Claire Keast-Butler
Partner, London
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
David Wilson
Partner, London
Chris Stack
Partner, London
Dayne Brown
Associate, New York
Margaret D. Suh
Associate, New York
Charles George
Associate, London
Meg Begur
Associate, London
Nicola Squire
Partner, London
Jack Jones
Associate, London
Charlotte Irvine
Associate, London
Tom Goodman
Partner, London
Paula Holland
Partner, London
Aaron Pomeroy
Partner, Colorado
Calvin Lee
Associate, New York
Ivor Elrifi
Partner, New York
Courtney Thorne
Partner, Boston

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Intellectual Property: Patent – New York (2021 – 2023)

Euromoney: Global Leader in Patent Law

Fellows of the American Bar Foundation: Elected Member

IAM Patent 1000: Leading Patent Lawyer

The Legal 500 US: Leading Lawyer in Healthcare: Lifesciences (2023)

LMG Life Sciences: Life Sciences Star, "Patent Strategy Attorney of the Year" (Winner, 2019; Finalist, 2020 - 2023)

Managing Intellectual Property: IP Star

Super Lawyers: Top IP Lawyer

Patent Strategy & Management Attorney of the Year

LMG Life Sciences, 2019